8,517 articles
David A. Scheinberg
David A. Scheinberg is an American physician-scientist at Memorial Sloan Kettering Cancer Center who treats leukemia and develops targeted cancer therapies, including alpha-particle radiopharmaceuticals and the WT1 vaccine.
David A. Shafritz
David A. Shafritz (1940–2025) was an American physician-scientist and hepatologist who spent over fifty years at Albert Einstein College of Medicine, directing its Marion Bessin Liver Research Center.
David A. Stevens
David A. Stevens is a Stanford physician-scientist in infectious diseases, known for work on fungal infections and for leading a San Jose research laboratory since 1973.
David A. Talan
David A. Talan is an American emergency medicine physician and infectious diseases researcher who built and led EMERGEncy ID NET and led the STOP MRSA and CODA trials.
David A. Thorley‐Lawson
David A. Thorley-Lawson was a British-born immunologist at Tufts University School of Medicine who proposed the germinal center model of Epstein-Barr virus latency and died in 2017.
David A. Warrell
David A. Warrell (D.A. Warrell), born 1939, is a British physician-scientist and Emeritus Professor of Tropical Medicine at Oxford, known for snakebite and malaria research.
David Aaron Kessler
David Aaron Kessler, born 1951, is an American pediatrician and lawyer who was FDA commissioner from 1990 to 1997 and later dean of the Yale and UCSF medical schools.
David Adams (cancer geneticist)
David J. Adams is a cancer geneticist at the Wellcome Sanger Institute in Cambridge, England, who studies somatic mutations driving melanoma and other skin cancers.
David Alastair Compston
David Alastair Compston, also known as David Alastair Standish Compston, is a British neurologist, Professor Emeritus at Cambridge, known for quantifying multiple sclerosis genetics and introducing alemtuzumab therapy.
David Alland
David Alland is an American infectious-diseases physician and researcher, professor and chief of infectious diseases at Rutgers New Jersey Medical School, who led development of the Xpert MTB/RIF tuberculosis diagnostic.
David Alpers
David H. Alpers is an American gastroenterologist and physician-scientist, emeritus William B. Kountz Professor at Washington University in St. Louis and a past president of the American Gastroenterological Association.
David Altshuler (geneticist)
David Altshuler is an American endocrinologist and human geneticist known for diabetes genetics and genome-wide association studies, and former chief scientific officer at Vertex Pharmaceuticals.
David Axelrod
David Axelrod is an American transplantation researcher whose work covers kidney discards, transplant quality measurement, and using the Epic Cosmos electronic health record database for transplant research.
David B. Allison
David B. Allison is an American biostatistician and obesity researcher, known for the 2016 Nature commentary "Reproducibility: A tragedy of errors" and elected to the National Academy of Medicine in 2012.
David B. Beck
David B. Beck is an American clinical geneticist who led the 2020 discovery of VEXAS syndrome and directs an inflammatory disease genetics program at NYU Langone Health.
David B. Corry
David B. Corry is an American physician-scientist in immunology and pulmonary medicine at Baylor College of Medicine who showed interleukin 13 drives asthma and proposed airway mycosis.
David B. Pryor
David B. Pryor is an American cardiologist and health-services researcher known for the Duke treadmill score, and was Chief Medical Officer of Ascension Health from 2001 to 2011.
David B. Reuben
David B. Reuben is an American geriatrician and health services researcher who was chief of UCLA's geriatrics division until 2024 and led major dementia care and falls trials.
David Blumenthal
David Blumenthal, born 1948, is an American physician and health policy researcher who served as US National Coordinator for Health Information Technology from 2009 to 2011.
David Bodian
David Bodian (1910–1992) was an American neuroscientist at Johns Hopkins whose research laid the groundwork for the Salk and Sabin polio vaccines, and who created the Bodian nerve stain.
David Bowtell
David Bowtell is an Australian cancer researcher at the Peter MacCallum Cancer Centre in Melbourne who identified molecular subtypes of ovarian cancer and led the Australian Ovarian Cancer Study.
David Bruce (microbiologist)
Sir David Bruce (1855–1931) was an Australian-born British army microbiologist who identified the organism causing Malta fever (brucellosis) and proved tsetse flies transmit trypanosomes; the genera Brucella and Trypanosoma brucei honor him.
David C. Christiani
David C. Christiani is a physician-scientist in molecular epidemiology at Harvard and Massachusetts General Hospital, known for studies of lung cancer, ARDS, and occupational lung disease.
David C. Dale
David C. Dale is an American physician-scientist and professor of medicine at the University of Washington since 1976, known for neutropenia research and G-CSF trials.
David C. Fajgenbaum
David C. Fajgenbaum is a University of Pennsylvania physician who researches Castleman disease and cytokine storm, and discovered sirolimus, a repurposed drug that has kept him in remission since 2012.
David C. Hooper
David C. Hooper is an infectious diseases physician and Harvard Medical School professor who led Massachusetts General Hospital's infection control unit and studies quinolone antibiotic resistance in bacteria.
David C. Linch
David C. Linch, also known as David Linch, is a British haematologist and Emeritus Professor at University College London known for leading UK trials in lymphoma and leukemia.
David C. Poskanzer
David C. Poskanzer was an American neurologist and epidemiologist at Massachusetts General Hospital and Harvard Medical School, known for his 1971 paper linking DES exposure to vaginal cancer.
David C. Wilbur
David C. Wilbur is an American cytopathologist, Professor of Pathology, Emeritus at Harvard Medical School, who led clinical trials of the first FDA-approved automated cervical cytology screening systems.
David C.S. Huang
David C.S. Huang, also known as David Ching Siang Huang, is a physician-scientist and laboratory head at WEHI in Melbourne whose Bcl-2 and apoptosis research underpinned the anti-cancer drug venetoclax.